Skye Bioscience's total assets for Q2 2024 were $87.26M, a decrease of -7.99% from the previous quarter. SKYE total liabilities were $14.45M for the fiscal quarter, a -9.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.